ZYBT Stock Analysis: Buy, Sell, or Hold?
ZYBT - Zhengye Biotechnology Holding Limited Ordinary Shares
$1.53
-0.20 (-11.56%)
▼
5d:
-80.9%
30d:
+101.02%
90d:
+66.32%
WAIT
LOW Confidence
Analysis Updated: Jul 27, 2026 12:00 AM ET
Earnings: Jul 28, 2026
0d
Get Alerted When ZYBT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: ZYBT is down 80.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: ZYBT is down 80.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: ZYBT is currently trading at $1.53, which is considered fair relative to its 30-day fair value range of $-0.22 to $2.67.
Technical Outlook: Technically, ZYBT is showing sideways momentum. Immediate support is located at $0.70, while resistance sits at $8.01. Short-term momentum is weak, with the stock down 11.6% recently.
Market Sentiment: ZYBT has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ZYBT is showing sideways momentum. Immediate support is located at $0.70, while resistance sits at $8.01. Short-term momentum is weak, with the stock down 11.6% recently.
Market Sentiment: ZYBT has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$-0.22 -
$2.67
Company Quality Score
55/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
73.5%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (75/100)
- BEARISH: Downward momentum (-11.6%)
- WARNING: Recommendation downgraded due to -80.9% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$-0.22 -
$2.67
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$0.70
Resistance Level
$8.01
Current Trend
Sideways
Technical data as of
Jul 27, 2026
Fundamental Context
Revenue Growth (YoY)
-40.9%
Earnings Growth (YoY)
-79.6%
Profit Margin
-60.0%
Share & Embed Analysis
Last updated: July 28, 2026 1:09 AM ET
Data refreshes hourly during market hours. Next update: 2:09 AM
Data refreshes hourly during market hours. Next update: 2:09 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ZYBT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$202 | 56 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$112 | 53 HOLD |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$114 | 48 HOLD |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$663 | 48 HOLD |
|
AVDL
Avadel Pharmaceuticals P… |
STRONG BUY
8 analysts |
$21 | 62 BUY |
